Giselle Sholler, Division Chief Pediatric Hematology/Oncology/BMT at Penn State Health Children’s Hospital, posted on LinkedIn about recent paper by Joseph Schramm et al., titled “Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy” published on MDPI.
Authors: Joseph Schramm, Chloe Sholler, Leah Menachery, Laura Vazquez, and Giselle Saulnier Sholler
“Grateful to Dr. Rupert Handgretinger for inviting us to contribute our review of DFMO in the Special Issue of High-Risk Neuroblastoma: New Clinical Insights and Challenges! Proud of my team and co-authors – Dr. Joe Schramm, Chloe Sholler, Leah Menachery and Laura Vazquez for our newest publication – Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy!”